Collaboration is essential. Therefore, we are focused on cultivating external partnerships that will complement and propel disease interception strategies. We are sharing the scientific resources and intellectual power of leading research organizations and are looking to support entrepreneurial, non-traditional, academic, pharmaceutical and biotech approaches.
Interested in exploring a possible collaboration with the Disease Interception Accelerator? Please contact us at Janssen_DIA@its.jnj.com for more information.